Compare AANJANEYA LIFECARE with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS FRESENIUS KABI ONCO. DR. DATSONS LABS/
FRESENIUS KABI ONCO.
 
P/E (TTM) x -10.9 22.1 - View Chart
P/BV x 0.2 3.1 5.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
FRESENIUS KABI ONCO.
Mar-13
DR. DATSONS LABS/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs126176 71.4%   
Low Rs3179 39.4%   
Sales per share (Unadj.) Rs133.037.7 352.9%  
Earnings per share (Unadj.) Rs0.25.1 3.0%  
Cash flow per share (Unadj.) Rs6.66.7 98.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.842.5 302.7%  
Shares outstanding (eoy) m31.66158.23 20.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.4 17.4%   
Avg P/E ratio x516.125.0 2,065.8%  
P/CF ratio (eoy) x11.818.9 62.6%  
Price / Book Value ratio x0.63.0 20.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47720,135 12.3%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m56703 8.0%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m4,2115,963 70.6%  
Other income Rs m7918 437.2%   
Total revenues Rs m4,2895,981 71.7%   
Gross profit Rs m5691,430 39.8%  
Depreciation Rs m204258 79.3%   
Interest Rs m430-26 -1,654.6%   
Profit before tax Rs m131,216 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m6342 1.8%   
Profit after tax Rs m5806 0.6%  
Gross profit margin %13.524.0 56.3%  
Effective tax rate %48.028.1 170.7%   
Net profit margin %0.113.5 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,8525,102 134.3%   
Current liabilities Rs m6,7112,385 281.3%   
Net working cap to sales %3.345.6 7.4%  
Current ratio x1.02.1 47.7%  
Inventory Days Days161150 107.2%  
Debtors Days Days318113 281.1%  
Net fixed assets Rs m3,6735,148 71.3%   
Share capital Rs m317158 200.1%   
"Free" reserves Rs m3,7616,556 57.4%   
Net worth Rs m4,0786,732 60.6%   
Long term debt Rs m1,671952 175.5%   
Total assets Rs m12,63310,388 121.6%  
Interest coverage x1.0-45.8 -2.2%   
Debt to equity ratio x0.40.1 289.7%  
Sales to assets ratio x0.30.6 58.1%   
Return on assets %3.47.5 45.9%  
Return on equity %0.112.0 1.0%  
Return on capital %7.714.6 52.5%  
Exports to sales %22.974.5 30.7%   
Imports to sales %14.324.8 57.7%   
Exports (fob) Rs m9644,441 21.7%   
Imports (cif) Rs m6021,477 40.7%   
Fx inflow Rs m9645,298 18.2%   
Fx outflow Rs m6071,772 34.3%   
Net fx Rs m3573,525 10.1%   
CASH FLOW
From Operations Rs m1,3451,274 105.5%  
From Investments Rs m-2,256-1,204 187.3%  
From Financial Activity Rs m-1,200-196 611.8%  
Net Cashflow Rs m-2,111-126 1,671.2%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 1.4 9.6 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 9.1 1,034.1%  
Shareholders   20,807 42,599 48.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  WOCKHARDT  AUROBINDO PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls Over 750 Points from Day's High; Metal and Realty Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed a sharp sell-off during closing hours today and ended lower.

Related Views on News

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS